The fetal growth restriction at term managed by angiogenic factors versus feto-maternal doppler (grafd) trial to avoid adverse perinatal outcomes: protocol for a multicenter, open-label, randomized controlled trial

HIGHLIGHTS

• who: Unknown from the Randomization, Masking, and Data Collection Participants will be randomly assigned to the intervention or control group in a, :, ratio using variable-size block randomizationThe randomization sequence will be centralized and generated by the web-based system Sealed Envelope (Sealed Envelope Ltd) and will be concealed to investigators. Owing to the nature of the intervention, it will not be possible to conceal the study group to the participants, investigators, or outcome assessors. A RedCap (Research Electronic Data Capture have published the paper: The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.